Japan, Jan. 28 -- FIVE PRIME THERAPEUTICS INC,BRISTOL MYERS SQUIBB CO has got intellectual property rights for 'ANTIBODIES BINDING TO ILT4.' Other related details are as follows:

Application Number: JP,2023-218223

Category (FI): A61K31/7088,A61K35/12,A61K38/02,A61K39/395@D,A61K39/395@N,A61K39/395@U,A61K45/00,A61K45/00,101,A61K47/68,A61K48/00,A61P31/00,A61P31/12,A61P35/00,A61P37/04,A61P43/00,111,C07K14/47,C07K16/28,C12N1/15,C12N1/19,C12N1/21,C12N15/13,C12N5/10,C12P21/08,C12Q1/04

Stage: Grant (IP right document published.)

Filing Date: Dec. 25, 2023

Publication Date: April 2, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....